The TearAD Study: Tear Biomarkers for Alzheimer's Disease (AD) Screening and Diagnosis

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 9, 2022

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
Alzheimer Disease
Interventions
DIAGNOSTIC_TEST

Tear Fluid collection (Schirmer's strip)

Tear fluid will be collected non-invasively form all participants with the use of Schirmer's strips, which is a small paper strip placed in the lower eye lid for a maximum of 5 minutes.

DIAGNOSTIC_TEST

Retinal imaging

The retina from all participants will be visualised with the use of a standard (Clarus 700 Zeiss), ultra-wide field (Optos), and cross-sectional (Optical Coherence Tomography) retinal images.

Trial Locations (2)

6229 HX

RECRUITING

Academic Hospital Maastricht, Maastricht

1081 HV

RECRUITING

Amsterdam University Medical Center, Amsterdam

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER